Evidence map›Paper›PMID 40662759›Full record

ArticleStatistics in medicine2025

Simultaneous Feature Selection for Optimal Dynamic Treatment Regimens.

Mochuan Liu, Yuanjia Wang, Donglin Zeng

Abstract read
In one paragraph

Article in Statistics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mochuan LiuDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0003-2663-4493
Yuanjia WangDepartment of Biostatistics, Columbia University, New York, New York, USA.ORCID https://orcid.org/0000-0002-1510-3315
Donglin ZengDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.

Funding

Statistical Methods for Integrating Mixed-type Biomarkers and Phenotypes in Neurodegenerative Disease ModelingR01NS073671 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2011 to 2025
$3.9M
Statistical and Machine Learning Methods to Improve Dynamic Treatment Regimens Estimation Using Real World Data.R01GM124104 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Yuanjia Wang, Donglin Zeng · 2018 to 2026
$3.1M
Machine Learning Methods for Optimizing Individualized Treatment Strategies for Precision PsychiatryR01MH123487 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2021 to 2025
$2.0M
Semiparametric Regression Analysis of Interval-Censored Data in Current Cohort StudiesR01HL173128 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Donglin Zeng · 2024 to 2026
$1.2M
NHLBI NIH HHS R01 HL173128NIGMS NIH HHS R01 GM124104NIH HHS GM124104NIH HHS MH123487NIH HHS NS073671NIMH NIH HHS R01 MH123487NINDS NIH HHS R01 NS073671
6 · The paper itself

Abstract

Dynamic treatment regimens (DTRs), where treatment decisions are tailored to individual patient's characteristics and evolving health status over multiple stages, have gained increasing interest in the modern era of precision medicine. Identifying important features that drive these decisions over stages not only leads to parsimonious DTRs for practical use but also enhances the reliability of learning optimal DTRs. Existing methods for learning optimal DTRs, such as Q-learning and O-learning, rely on a sequential procedure to estimate the optimal decision at each stage backward. Incorporating feature selection in these methods through regularization at each stage of estimation only identifies unimportant tailoring variables at each stage but is not necessary for those variables that are not important across all the stages. As a result, false discovery errors are likely to accumulate over stages in these sequential methods. To overcome this limitation, we propose a framework, namely L1 multistage ramp loss (L1-MRL) learning, to learn the optimal decision rules and, at the same time, perform variable selection across all the stages simultaneously. This framework uses a single multistage ramp loss to estimate optimal DTRs for all stages. Furthermore, a group Lasso-type penalty is imposed to penalize the coefficients in the decision rules across all stages, which enables the identification of features that are important for at least one stage decision. Theoretically, we show that the estimator is consistent and enjoys the oracle property toward the optimal. We demonstrate that the proposed method performs equally well as or better than many existing DTR methods with variable selection capability via extensive simulation studies and an application to electronic health record (EHR) data for type 2 diabetes (T2D) patients.

Indexed as

Precision MedicineAlgorithmsComputer SimulationDiabetes Mellitus, Type 2HumansMachine LearningModels, Statisticaldecision‐makingdynamic treatment regimensgroup lassoramp loss functionvariable selection

Identifiers

PMID40662759
PMCPMC12261976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.